TMCnet News

Cirrhosis - Pipeline Insight, 2018 by Pipeline Therapeutics, Discovery Stage, Therapeutic Assessment, Inactive Products & Comparative Analysis - ResearchAndMarkets.com
[February 22, 2018]

Cirrhosis - Pipeline Insight, 2018 by Pipeline Therapeutics, Discovery Stage, Therapeutic Assessment, Inactive Products & Comparative Analysis - ResearchAndMarkets.com


The "Cirrhosis - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Cirrhosis - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cirrhosis development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Cirrhosis pipeline proucts by developmental stage, product type, molecule type, and administration route.



Key Topics Covered:

1. Report Introduction


2. Cirrhosis Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Cirrhosis

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • Hebei Medical University Pharmaceutical Factory
  • Valeant Pharmaceuticals International Inc.
  • Intercept Pharmaceuticals
  • Pfizer
  • AbbVie
  • Gilead Sciences
  • Merck Sharp (News - Alert) & Dohme Corp.
  • BioVie Inc
  • Conatus Pharmaceuticals Inc.
  • CymaBay Therapeutics Inc.
  • Can-Fite BioPharma
  • Gilead Sciences
  • Novartis Pharmaceuticals
  • Shanghai Genomics Inc.
  • Mina Alpha Limited

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/xg528w/cirrhosis?w=4


[ Back To TMCnet.com's Homepage ]